Pfizer News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Orderbuch

Analysen

Historisch

03.11.22	Pfizer's Elranatamab Gets Breakthrough Therapy Designation From FDA For R/R Multiple Myeloma (RTTNews)
03.11.22	Pfizer’s Elranatamab Granted FDA Breakthrough Therapy Designation for Relapsed or Refractory Multiple Myeloma (Businesswire)
01.11.22	Pfizer Reports Positive Top-Line Trial Data For Bivalent RSV Vaccine Candidate (RTTNews)
01.11.22	Pfizer Boosts FY22 Outlook As Q3 Results Top Estimates (RTTNews)
01.11.22	Pfizer Inc. Reveals Advance In Q3 Income (RTTNews)
01.11.22	PFIZER REPORTS STRONG THIRD-QUARTER 2022 RESULTS AND RAISES 2022 OUTLOOK (Businesswire)
01.11.22	Pfizer Announces Positive Top-Line Data of Phase 3 Global Maternal Immunization Trial for its Bivalent Respiratory Syncytial Virus (RSV) Vaccine Candidate (Businesswire)
01.11.22	Form 8-K 78003 (RSS)
28.10.22	GSK: EMA Validates ViiV Healthcare's MAA For Cabotegravir Long-acting Injectable For HIV Prevention (RTTNews)
28.10.22	ViiV Healthcare : EMA Validates MAA For Cabotegravir Long-acting Injectable For HIV Prevention (RTTNews)
21.10.22	Pfizer Likely To Hike U.S. COVID Vaccine Price (RTTNews)
20.10.22	Pfizer-BioNTech's COVID-19 Vaccine Recommended In EU For Children Under 5 Yrs (RTTNews)
18.10.22	Pfizer Presents Scientific Advancements in Infectious Disease Prevention and Treatments at IDWeek 2022 (Businesswire)
13.10.22	Pfizer- BioNTech Early Study Data For Omicron BA.4/BA.5-Adapted Bivalent Booster Vaccine, Positive (RTTNews)
13.10.22	Pfizer and BioNTech Announce Positive Early Data From Clinical Trial of Omicron BA.4/BA.5-Adapted Bivalent Booster in Individuals 18 Years and Older (Businesswire)
12.10.22	Pfizer : FDA Grants Emergency Use Of Omicron Bivalent COVID-19 Vaccine Booster In Children (RTTNews)
12.10.22	Pfizer and BioNTech Receive U.S. FDA Emergency Use Authorization for Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine Booster in Children 5 Through 11 Years of Age (Businesswire)
05.10.22	Pfizer Completes Acquisition of Global Blood Therapeutics (Businesswire)
04.10.22	Pfizer Reports Positive Topline Results From Phase 3 TALZENNA Trial (RTTNews)
04.10.22	Pfizer Announces Positive Topline Results from Phase 3 TALAPRO-2 Trial (Businesswire)
03.10.22	Pfizer Completes Acquisition of Biohaven Pharmaceuticals (Businesswire)
26.09.22	Pfizer, BioNTech Apply For EUA In US Of Omicron BA.4/BA.5-Adapted Bivalent Vaccine Booster In Kids (RTTNews)
26.09.22	Pfizer and BioNTech Submit Application to U.S. FDA for Emergency Use Authorization of Omicron BA.4/BA.5-Adapted Bivalent Vaccine Booster in Children 5 Through 11 Years of Age (Businesswire)
22.09.22	Pfizer Declares Fourth-Quarter 2022 Dividend (Businesswire)
22.09.22	Pfizer To Supply 6 Mln Paxlovid Treatment Courses To Fight Covid-19 (RTTNews)
22.09.22	Pfizer to Supply Global Fund Up to 6 Million PAXLOVID™ Treatment Courses for Low-and-Middle-Income Countries (Businesswire)
20.09.22	Pfizer Invites Public to View and Listen to Webcast of November 1 Conference Call with Analysts (Businesswire)
19.09.22	Pfizer Posts Positive Study Data In 20-Valent Pneumococcal Conjugate Vaccine In Infants In EU (RTTNews)
19.09.22	Pfizer Announces Positive Top-Line Results from Phase 3 Study in 20-Valent Pneumococcal Conjugate Vaccine in Infants in the European Union (Businesswire)
16.09.22	Pfizer - BioNTech COVID-19 Vaccine Recommended For Full Approval In EU (RTTNews)
15.09.22	Pfizer Says Late-stage Study Of Pentavalent Meningococcal Vaccine Candidate Met Primary Goal (RTTNews)
15.09.22	Pfizer Announces Positive Top-Line Results from Phase 3 Trial of Pentavalent Meningococcal Vaccine Candidate (MenABCWY) in Adolescents (Businesswire)
14.09.22	Pfizer Invites Public to View and Listen to Webcast of Analyst and Investor Call to Review Oral GLP-1 Data Presented at European Association for the Study of Diabetes (EASD) 2022 (Businesswire)
14.09.22	Pfizer Doses First Participants In Phase 3 Study Of MRNA-Based Influenza Vaccine (RTTNews)
14.09.22	Pfizer Initiates Phase 3 Study of mRNA-Based Influenza Vaccine (Businesswire)
13.09.22	Pfizer To Provide Therapeutics For Strata PATH Trial - Quick Facts (RTTNews)
13.09.22	Strata Oncology Announces Expansion of Clinical Collaboration with Pfizer for Strata PATH Trial into Early-Stage Cancer (PR Newswire)
13.09.22	Pfizer And BioNTech Receive Positive CHMP Opinion For Omicron COVID-19 Vaccine Booster In EU (RTTNews)
12.09.22	Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine Booster in European Union (Businesswire)
09.09.22	Pfizer : FDA And EMA Accept Regulatory Submission For Ritlecitinib For Alopecia Areata (RTTNews)
09.09.22	FDA and EMA Accept Regulatory Submission for Pfizer’s Ritlecitinib for Individuals 12 Years and Older with Alopecia Areata (Businesswire)
07.09.22	Pfizer Says Its Group B Streptococcus Vaccine Candidate Got Breakthrough Therapy Designation (RTTNews)
07.09.22	FDA Grants Breakthrough Therapy Designation to Pfizer’s Group B Streptococcus Vaccine Candidate to Help Prevent Infection in Infants Via Immunization of Pregnant Women (Businesswire)
06.09.22	Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference (Businesswire)
06.09.22	Pfizer Invites Public to View and Listen to a Webcast of Pfizer Discussion on Climate Action (Businesswire)
01.09.22	Adapted Versions Of Pfizer's Comirnaty & Moderna's Spikevax Recommended For Approval In The EU (RTTNews)
01.09.22	Pfizer Invites Public to View and Listen to Two Webcasts of Pfizer Discussions at Healthcare Conferences (Businesswire)
01.09.22	Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron BA.1-Adapted Bivalent COVID-19 Vaccine Booster in European Union (Businesswire)
01.09.22	FDA Authorizes Moderna, Pfizer-BioNTech Omicron Boosters (RTTNews)
31.08.22	Pfizer - BioNTech Granted FDA Emergency Use Authorization Of Omicron COVID-19 Vaccine Booster (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Part Grp Hldg	1’263.50	2.89 %	K V
Sonova Hldg	312.10	2.66 %	K V
Novartis	93.68	2.32 %	K V
Geberit	526.80	1.97 %	K V
Roche Hldg G	254.30	1.27 %	K V
Kuehne+Nagel Int	209.50	0.72 %	K V
UBS Group	28.30	0.57 %	K V
Givaudan	3’933.00	0.36 %	K V
Nestle	76.00	0.05 %	K V
Lonza Grp	521.40	-0.04 %	K V

mehr

22.11.24		Dow Jones aktuell: Dow Jones zum Ende des Freitagshandels in der Gewinnzone
22.11.24		Freundlicher Handel in New York: Dow Jones präsentiert sich am Freitagnachmittag fester
22.11.24		Börse New York in Grün: Dow Jones bewegt sich am Mittag im Plus
22.11.24		Zuversicht in London: FTSE 100 beendet die Freitagssitzung in der Gewinnzone
22.11.24		Gute Stimmung in Europa: Anleger lassen STOXX 50 letztendlich steigen
22.11.24		Handel in Frankfurt: TecDAX letztendlich in Grün
22.11.24		Freundlicher Handel: Börsianer lassen SPI schlussendlich steigen

22.11.24

Dow Jones aktuell: Dow Jones zum Ende des Freitagshandels in der Gewinnzone

22.11.24

Freundlicher Handel in New York: Dow Jones präsentiert sich am Freitagnachmittag fester

22.11.24

Börse New York in Grün: Dow Jones bewegt sich am Mittag im Plus

22.11.24

Zuversicht in London: FTSE 100 beendet die Freitagssitzung in der Gewinnzone

22.11.24

Gute Stimmung in Europa: Anleger lassen STOXX 50 letztendlich steigen

22.11.24

Handel in Frankfurt: TecDAX letztendlich in Grün